The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
conversely T3 has a much shorter Half-Life and therefore you do need to stay on top of your T3 when you give it now of course remember the control release in the immediate release T3 also have very different half-lives but what I'm referring to is endogenous T3 as well
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
conversely T3 has a much shorter Half-Life and therefore you do need to stay on top of your T3 when you give it now of course remember the control release in the immediate release T3 also have very different half-lives but what I'm referring to is endogenous T3 as well